Market Overview

UPDATE: Credit Suisse Initiates Constellium on Cheap Play and Margin Self-Help

Share:
Related CSTM
Mid-Afternoon Market Update: Celator Pharmaceuticals Surges On Phase 3 Trial Results For Vyxeos; Constellium Shares Slide
Earnings Scheduled For March 15, 2016

In a report published Tuesday, Credit Suisse analyst J. Mitchell initiated coverage on Constellium (NYSE: CSTM) with a rating of Outperform and a $20 price target.

In the report, Credit Suisse noted, “We think the stock offers an attractive combination of high exposure to growth markets in Aerospace and substantial self-help potential (margin expansion), coupled with a cheap valuation.”

Constellium closed on Monday at $16.25.

Latest Ratings for CSTM

DateFirmActionFromTo
Mar 2016JP MorganMaintainsOverweight
Mar 2016Credit SuisseInitiates Coverage onOutperform
Oct 2015CitigroupMaintainsNeutral

View More Analyst Ratings for CSTM
View the Latest Analyst Ratings

Posted-In: Credit Suisse J. MitchellAnalyst Color Initiation Analyst Ratings

 

Related Articles (CSTM)

View Comments and Join the Discussion!